Odisha sees surge in fake medicines; 4 suppliers blacklisted in 3 years

Bhubaneswar: Odisha registered a huge surge in counterfeit or fake medicines in a past few years, putting lives of many patients at risk.

This was revealed from a statement by Odisha Health & Family Welfare Minister Dr. Mukesh Mahaling in Assembly today.

According to reports, the fake medicines were supplied from other places like Uttar Pradesh, Madhya Pradesh, Kolkata and Hyderabad.

Replying to a query by BJP’s Dharamgarh MLA Sudhir Ranjan Pattjoshi, the Minister stated that 103 medicines procured by Odisha State Medical Corporation were found substandard and 4 suppliers have been blacklisted in past 3 years.

“Total 45 tablets and Ringer’s Lactate including Zinc Suplphate, Sodium Lactate were declared as substandard in 2022-23 FY, 32 medicines were found falsified during 2023-24 FY and 26 fake medicines were found fake in 2024-25 FY,” Dr. Mahaling stated.

As part of measure to prevent supply of counterfeit medicines in the state, the government has blacklisted four suppliers so far. The blacklisted pharmaceutical firms were LA CHEMICO Pvt Ltd, Kolkata; Swaroop Pharmaceutical Pvt Ltd, Uttar Pradesh; Ives Drugs India Pvt Ltd, Madhya Pradesh; and Alliance Biotech, Hyderabad, he said.

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states